Vanderbilt University Medical Center is leading a clinical trial to understand if hydroxychloroquine, a well-known drug used for malaria and rheumatologic conditions, is safe and effective in treating hospitalized adults with COVID-19.
A team including health economists, epidemiologists and a biostatistician at Vanderbilt University Medical Center and Vanderbilt University are amassing and processing data to develop a complex predictive model of the spread of COVID-19 within Tennessee, with region-specific projections, as well as a model of projected resource use during response to the pandemic.
Scientists are reporting promising results for a new drug to treat COVID-19. The drug is known as EIDD-2801. It works by interfering with the coronavirus’ ability to make copies of itself once it infects a cell. In that regard it’s similar to remdesivir, a drug currently being tested in COVID-19 patients. Researchers from Emory University … Continued
Vanderbilt University Medical Center is teaming up with academic, governmental and corporate partners in an unprecedented, fast-tracked global effort to develop antibody-based treatments to protect people exposed to COVID-19. “Our goal is to prepare antibodies for human clinical trials by this summer,” said James Crowe, MD, director of the Vanderbilt Vaccine Center. “We have ultra-rapid … Continued
As COVID-19 continues to push unprecedented challenges on medical communities, one of the most pressing threats for hospital staff across the country is a dwindling supply of ventilators. In this video, an interdisciplinary team of Vanderbilt University and Vanderbilt University Medical Center faculty show how to use common materials to build a ventilator.
Under a recently signed agreement, genetic sequences for antibodies discovered in the Vanderbilt Vaccine Center will be provided to AstraZeneca for identification of the most promising candidates for clinical assessment and future clinical use.